EXPERTS IN CANNABIS OIL AND CONCENTRATES · Pepsi and Johnson & Johnson, with various brand and field marketing assignments • MBA from The Ander School at UCLA in Marketing and

EXPERTS IN CANNABIS OIL AND CONCENTRATES

INVESTOR PRESENTATION February 2019

NEO SYMBOL: HALOOTCQB: AGEEF

GERMANY: A9KN www.halocanna.com

DISCLOSURESThis presentation of ANM, Inc. (the “Company”) is for information only and shall not constitute an offer to buy, sell, issue or subscribe for, or the solicitation of an offer to buy, sell or issue, or subscribe for any securities. The information contained herein is subject to change without notice and is based on publicly available information, internally developed data and other sources. Where any opinion or belief is expressed in this presentation, it is based on the assumptions and limitations mentioned herein and is an expression of present opinion or belief only. No warranties or representations can be made as to the origin, validity, accuracy, completeness, currency or reliability of the information. The Company disclaims and excludes all liability (to the extent permitted by law), for losses, claims, damages, demands, costs and expenses of whatever nature arising in any way out of or in con-nection with the information in this presentation, its accuracy, completeness or by reason of reliance by any person on any of it. This presentation should not be construed as legal, financial or tax advice to any individual, as each individual’s circumstances are different. Readers should consult with their own professional advisors regarding their particular circumstances. The information contained in this presentation is not directed to persons or entities resident in the United States and does not constitute an offer or solicitation by anyone in the United States or in any other jurisdiction in which such an offer or solicitation is not authorized or to any person to whom it is unlawful to make such an offer or solicitation, unless otherwise exempt from United States securities legislation.

THE SECURITIES DESCRIBED IN THE PRESENTATION HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933 (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE U.S. AND THE SECURITIES MAY NOT BE OFFERED OR SOLD WITHIN THE U.S., EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT, THE REGISTRATION REQUIRE-MENTS OF THE SECURITIES ACT AND APPLICABLE STATE OR LOCAL SECURITIES LAWS.

FORWARD-LOOKING STATEMENTS Certain statements in this presentation are “forward-looking statements”. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always using words or phrases such as “expect”, “seek”, “endeavor”, “anticipate”, “plan”, “estimate”, “believe”, “intend”, or stating that certain actions, events or results may, could, would, might or will occur or be taken, or achieved) are not statements of historical fact and may be “forward-looking statements”. Forward-looking statements are based on expectations, estimates and projections at the time the statements are made and involve significant known and unknown risks, uncertainties and assumptions which would cause actual results or events to differ materially from those presently anticipated. A number of factors could cause actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward- looking statements. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward- looking statements prove incorrect, actual results, performance or achievements could vary materially from those ex-pressed or implied by the forward-looking statements contained in this document. Investors should not place undue reliance on these forward-looking statements. Although the forward-looking statements contained in this document are based upon what the Company’s management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. Except as required by law, the Company does not have any obligation to advise any person if it becomes aware of any inaccuracy in or omission from any forward-looking statement, nor does it intend, or assume any obligation, to update or revise these forward-looking statements to reflect new events or circumstances.

FUTURE ORIENTED FINANCIAL INFORMATION To the extent any forward-looking information in this presentation constitutes “future-oriented financial information” or “financial outlooks” within the meaning of applicable Canadian securities laws, such information is being provided to demonstrate the anticipated market penetration and the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such future-oriented financial information and financial outlooks. Future oriented-financial information and financial outlooks, as with forward-looking information generally, are, without limitation, based on the assumptions and subject to the risks set out above under the heading “ Forward Looking Statements”. The Company’s actual financial position and results of operations may differ materially from management’s current expectations and, as a result, the Company’s revenue and expenses may differ materially from the revenue and expenses profiles provided in this presentation. Such information is presented for illustrative purposes only and may not be an indica-tion of the Company’s actual financial position or results of operations.

MARKET RESEARCH AND PUBLIC DATAThis presentation contains or references certain market, industry and peer group data which is based upon information from independent industry publications, market research, analyst reports and surveys and other publicly available sources. Although the Company believe these sources to be generally reliable, such information is subject to interpretation and cannot be verified with complete certainty due to limits on the availability and reli-ability of raw data, the voluntary nature of the data gathering process and other inherent limitations and uncertainties. The Company has not independently verified any of the data from third party sources referred to in this presentation and accordingly, the accuracy and completeness of such data is not guaranteed. This presentation is confidential and is being provided to you solely for your information and may not be reproduced, in whole or in part, in any form or forwarded or further distributed to any other person. Any forwarding, distribution or reproduction of this document in whole or in part is unauthorized. By accepting and reviewing this presentation, you acknowledge and agree (i) to maintain the confidentiality of this document and the information contained herein, (ii) to protect such information in the same manner you protect your own confidential information, which shall be at least a reasonable standard of care and (iii) to not utilize any of the information contained herein except to assist with your evaluation of the Company.

1

HALO INVESTMENT HIGHLIGHTS



A Leading Manufacturer of Cannabis Oils & Concentrates in United States

Launched in California in November 2018, Nevada in October 2018 & Oregon in April 2016

Meaningful Current Revenue with Robust Growth Forecast

Proven and Skilled Operators with Industry Expertise and Blue Chip Pedigrees

Trading at a Significant Discount to both US and Canadian Peers

2

MANUFACTURING IN CALIFORNIA SINCE NOVEMBER 2018

15,500 sq ft.licensed volatile & non-volatile

processing facilities in Cathedral City

+25,000 gramsper day estimated production

capacity

US $90 MM annual(1) potential run-rate

US $2.2 MMmonthly extraction contract signed

with Falcon International



(1) Estimated date pending completion of build out and perfection of licenses

3

MANUFACTURING AND SELLING IN NEVADA SINCE OCTOBER 2018

8,000 sq ft.licensed processing facility by

Las Vegas Airport

15,000 gramsper day estimated production

capacity

2 Licensesmanufacturing and

cultivation with distribution pending

3 Brandsand 1 private label launched

across 18 dispensaries



4

A LEADING MARKET SHARE POSITION IN HIGHLY COMPETITIVE OREGON MARKET

+3MM Gramssold since April 2016

US$25MM+in revenue to date in Oregon(1)

+20% Market Sharein wholesale concentrates(2)

19,200 sq. ft.manufacturing facility in Medford, Oregon(3)

6 Acresof outdoor canopy

in Jackson County(4)

+36 Monthsoperating history in a highly

regulated environment



(1) Company prepared financials (2) BDS Analytics Q4 2017. Share calculated by converting sales dollars to units and comparing to ANM monthly unit sales. Unstable retail prices make unit shareconsumption more relevant. Currently ranked #2 in state by volume. (3) The facility ahs approximately 12,000 sq feet of indoor manufacturing space, as well as an enclosed courtyard of approximately 7,200sq feet. (4) 2 acres are under contract, 4 acres are owned by Halo Labs.

5

INTERNATIONAL PARTNERSHIPS IN AFRICA & EUROPE

14 Hectareland package off-take agreement

in Lesotho Africa

Active Discussions with potential European based

partnerships

20% Stake and $0.50-2.00 royalty on

signed LOI in Lesotho Africa



6

ACCELERATED REVENUE GROWTH WITH CALIFORNIA & NEVADA 2019 EXPANSION

HALO Revenue Forecast



US $50,000,000

US $37,500,000

US $25,000,000

US $12,500,000

US $02016 2017 2018 2019E

7

PHO C02 CHEMICAL



SOLVENT:

PropaneSOLVENT:

Supercritical C02

SOLVENT:

Proprietary Solvent

BENEFITS: Artisan Product

BENEFITS: Milder &

Smoother

BENEFITS: Benefits Purity

BHOSOLVENT:

Butane

BENEFITS: Efficient &

Potent Yields

PRODUCTS: Shatter, Wax,

Crumble, Dabs & Cartridges

PRODUCTS: Shatter, Wax,

Crumble, Dabs & Cartridges

PRODUCTS: Edibles &

Cartridges

PRODUCTS: THC-A and CBD

Crystals

ESTABLISHED EXPERTISE IN ALL MAJOR MANUFACTURING PROCESSES

8

DEVELOPING BRANDS & PROVIDING WHITE LABEL MANUFACTURING



HALO white label sales ~35% of current revenue. We expect it to grow to over 50% by 2019

WHITE LABEL IN-HOUSE BRANDS

9

PROVEN AND EXPERIENCED OPERATORS WITH INNOVATIVE PRODUCTS



Shatter DistillateCrumble BudderRosin SauceBubble Hash Live Resin & More

• No-mess Dabbing Solution

• Revolutionary Dabbing Experience

• Dry to the Touch, Portable

• Precise Dosing & Filling

• Toxin-Free Material

• Patents Pending

by

WORKS WITH A VARIETY OF CANNABIS EXTRACTS

10

Launched DabTabs in Oregon in January 2019, Nevada February 2019, and California launch expected March 2019

KIRAN SIDU

CEO & Director

• Former Chairman, CEO andFounder of Transact Networka leading EU electronic moneyinstitution – sold to Bancorp(NYSE:TBBK) in 2011

• Governance Committee ChairNamaste (TSX-V:N) Canada’s firstlicensed sales LP operating 24websites in 20 countries

• Former CFO of On StageEntertainment (NASDAQ:ONST),led IPO

• PWC in the strategic consultinggroup and with Merrill LynchCapital Markets in M&A

• AB Brown University andMBA Wharton University ofPennsylvania

PHILIP VAN DEN BERG

CFO & Director

• Director covering EuropeanEquities at Goldman Sachs

• Founding Partner of Taler AssetManagement & Co-Founder ofOlympus Capital, a long/shorthedge fund

• CFO of Namaste (TSX-V:N)

• Former Director and 1st CFO ofGolden Leaf Holdings (CSE:GLH);Led Canadian RTO raising +$20MM

AN EXPERIENCED MANAGEMENT TEAM WITH INDUSTRY EXPERTISE & BLUE-CHIP PEDIGREES



ANDREAS MET

COO & Director

• Former Senior Merchant atWalmart, managed HouseholdChemicals Desk with $5B inrevenue and $1B profit

• Former Head of Sales & Marketingat Golden Leaf (CSE:GLH) ledmonthly revenues from $0 to over$1MM

• MBA from University of Wisconsinin Product and Price Marketing

DAVID ORR

Chief Revenue Officer

• Innovative Sales & Marketingexecutive with 20+ years of CPGexperience

• Former Senior Sales Directorat PepsiCo, managed retail andecommerce sales team andcustomer relationships across allfood & beverage divisions

• Former Marketing Director atPepsi and Johnson & Johnson,with various brand and fieldmarketing assignments

• MBA from The Ander Schoolat UCLA in Marketing andInternational BusinessManagement

CHRIS FLORIAN

VP Sales

• Former Sr. Key Account Managerfor Anheuser-Busch InBev,responsible for growing 2.5MMcases annually in CVS

• Former Category Manager atAnheuser-Busch InBev responsiblefor growing 4MM cases annually in#3 Kroger Banner

• Former National Account Managerfor a Global Leader in DistilledSpirits

11

VETERAN BOARD OF INDEPENDENT DIRECTORS & MEDICAL ADVISORS



G. SCOTT PATERSON

Chairman (1) (2)

• Technology, media & cannabisventure capitalist

• Director of Lion GateEntertainment (NYSE:LGF) andChair of the Company’s Audit &Risk Committee

• Former Chairman & CEO ofYorkton Securities

• Former Chairman of CanadianVenture Stock Exchange & FormerVice Chairman of Toronto StockExchange

PETER MCRAE

CEO & Director

• 30+ years experience in thefinancial services industry

• Chairman of FreedomInternational Brokerage havingserved as its President & CEO

• Director of Eco Oro Minerals,Founders Advantage Capitaland Merry Go Round Children’sFoundation

FRED LEIGH

COO & Director

• 35+ Years experience in the juniorresource sector including foundingSiwash Holdings Ltd

• Current President of RoutmasterCapital a listed investmentcompany with royalties and severalinvestments in public mining

DR. KRASNOPEROV

Science Advisor & Founding Shareholder

• Research & DevelopementDirector at Vasgene Therapeutics

• 30+ Years experience inbiochemistry research and processimplementation

• Research Scientist at New YorkUniversity, and NottinghamUniversity, UK, Department of LifeScience

• Awarded grants by SorosFoundation and NIH, and hasco-authored 50+ peer reviewedpublications to date

(1) G. Scott Paterson maintains the right to nominate an additional directorto the board. (2) Pending regulatory approval. Notes: Kiran Sidahu (CEO),Andreas Met (CMO), Philip Van den Berg (CFO) are Directors as well

12

OPTIONS 0/S (w.a. C$0.47)

CURRENT CAPITALIZATION STRUCTURE

COMMON SHARES O/S

PHO



167.4M

$102.1M $104M

130.8M 12.3M

Warrants Outstanding (w.a. C$0.74)

CURRENT MARKET CAP @ C$0.61

POTENTIAL CASH FROM EXERCISE OF WARRANTS &

OPTIONS

13

TRADING AT 1.6X 2019 EV/SALES VS US PEERS AT 6.9X



(in C$MM except per share amounts) 2019 ESTIMATES EV/2019E

COMPANY TICKER PRICE (C$)FD ITM SHARES

(MM)ADJ. MCAP(1) EV BUSINESS LINES KEY JURISDICTION REVENUE EBITDA REVENUE EBITDA

CURA-CA $10.25 489 $5,008 $4,667 Flower/Dispensary Various $451 $163 10.4x 28.7x

ACRG. U-CA $27.49 116 $3,201 $2,876 Flower/Dispensary Various $359 $80 8.0x 36.1x

HARV-CA $10.60 297 $3,144 $2,910 Flower/Dispensary/Oil Various $306 $77 9.5x 37.9x

GTII-CA $19.69 160 $3,141 $3,108 Flower/Dispensary IL, PA, MD, OH, MA, FL, NV $297 $69 10.5x 45.1x

CWEB-CA $18.15 107 $1,934 $1,824 Hemp/Oil Various $218 $77 8.4x 23.6x

MMEN-CA $4.08 503 $2,054 $2,134 Various/Financing CA, NV, NY, FL, MA $428 N/A 5.0x N/A

TRUL-CA $17.96 110 $1,982 $1,956 Flower/Dispensary FL $290 $120 6.7x 16.3x

IAN-CA $7.75 222 $1,717 $1,506 Various/Financing CO, NY, VT, MA, NM, FL $218 $35 6.9x 42.8x

MRMD-CA $4.86 229 $1,111 $1,100 Flower/Dispensary DE, RI, NV, MD, MA N/A N/A N/A N/A

OH-CA $9.02 72 $648 $552 Various/Financing CA, CAN $163 $19 3.4x 29.2x

LHS-CA $1.20 372 $446 $413 Flower/Dispensary FL $75 $13 5.5x 31.4x

PLTH-CA $1.86 150 $278 $221 Flower/Dispensary NV $123 $29 1.8x 7.7x

CNNX-CA $1.19 226 $269 $214 Oil/Flower WA, CA $21 $14 10.0x 15.7x

SNN-CA $5.20 43 $222 $190 Flower/Oil/Clinics/Dist. CA, CAN N/A N/A N/A N/A

TGIF-CA $0.42 269 $114 $107 Flower/Oil/Services NV, CO, CA $35 $7 3.0x 15.1x

CuraLeaf

Acreage Holdings

Harvest

Green Thumb

Charlotte’s Web

MedMen

Trulieve

iAnthus

MariMed

Origin House

Liberty Health

Planet 13

Cannex

Sunniva

1933 Industries

Median (US Companies) 6.9x 28.9x

HALO $0.61 217 $132 $108 Oil/Flower OR, NV, CA $66 $13 1.6x 8.2x

Source: Company disclosure, FactSet and analyst estimates as of February 19, 2019. Note: Assumes a CAD:USD FX rate of 0.75.

14

HALO INVESTMENT HIGHLIGHTS



A Leading Manufacturer of Cannabis Oils & Concentrates in Oregon

Launched in California in November 2018, Nevada in October 2018 & Oregon in April 2016

Meaningful Current Revenue with Robust Growth Forecast

Proven and Skilled Operators with Industry Expertise and Blue Chip Pedigrees

Trading at a Significant Discount to both US and Canadian Peers

16

CONTACT INFO

[email protected]

Investor Relations

www.halocanna.com

NEO SYMBOL: HALO

17



EXPERTS IN CANNABIS OIL AND CONCENTRATES · Pepsi and Johnson & Johnson, with various brand and field marketing assignments • MBA from The Ander School at UCLA in Marketing and

Documents